Stifel Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
225,640
+60,816
| +37% | +$105K | ﹤0.01% | 2910 |
|
|
2025
Q1 | $549K | Sell |
164,824
-45,175
| -22% | -$150K | ﹤0.01% | 2625 |
|
|
2024
Q4 | $1.55M | Sell |
209,999
-13,108
| -6% | -$97K | ﹤0.01% | 1955 |
|
|
2024
Q3 | $2.09M | Buy |
223,107
+58,787
| +36% | +$552K | ﹤0.01% | 1736 |
|
|
2024
Q2 | $1.32M | Sell |
164,320
-93,975
| -36% | -$754K | ﹤0.01% | 1991 |
|
|
2024
Q1 | $3.83M | Sell |
258,295
-50,459
| -16% | -$748K | ﹤0.01% | 1307 |
|
|
2023
Q4 | $2.51M | Buy |
308,754
+78,600
| +34% | +$639K | ﹤0.01% | 1518 |
|
|
2023
Q3 | $1.05M | Sell |
230,154
-96,179
| -29% | -$438K | ﹤0.01% | 2023 |
|
|
2023
Q2 | $2.3M | Buy |
326,333
+177,440
| +119% | +$1.25M | ﹤0.01% | 1537 |
|
|
2023
Q1 | $910K | Buy |
148,893
+10,968
| +8% | +$67K | ﹤0.01% | 2121 |
|
|
2022
Q4 | $881K | Buy |
+137,925
| New | +$881K | ﹤0.01% | 2092 |
|
|
2021
Q4 | – | Sell |
-8,735
| Closed | -$215K | – | 3411 |
|
|
2021
Q3 | $215K | Buy |
8,735
+135
| +2% | +$3.32K | ﹤0.01% | 3097 |
|
|
2021
Q2 | $224K | Sell |
8,600
-18,702
| -69% | -$487K | ﹤0.01% | 3076 |
|
|
2021
Q1 | $864K | Sell |
27,302
-4,916
| -15% | -$156K | ﹤0.01% | 2090 |
|
|
2020
Q4 | $1.5M | Buy |
32,218
+941
| +3% | +$43.7K | ﹤0.01% | 1566 |
|
|
2020
Q3 | $1.03M | Buy |
31,277
+1,050
| +3% | +$34.6K | ﹤0.01% | 1608 |
|
|
2020
Q2 | $830K | Sell |
30,227
-2,183
| -7% | -$59.9K | ﹤0.01% | 1698 |
|
|
2020
Q1 | $969K | Sell |
32,410
-6,970
| -18% | -$208K | ﹤0.01% | 1464 |
|
|
2019
Q4 | $1.09M | Buy |
+39,380
| New | +$1.09M | ﹤0.01% | 1764 |
|